Clinical Care posts displayed by category

drinking-study

Is Your Drinking out of Control?

A clinical trial is being conducted on an investigational medication for the treatment of heavy drinking. This study is open to men and women ages 18 and older and of European ancestry. Participation is confidential and you will be compensated for your time and effort. Transportation can be provided.

UMB IRB HP 00061575

University of Maryland
School of Medicine
Department of Psychiatry
Clinical Neurobehavioral Center

For more information call the Clinical Neurobehavioral Center (CNC) at (667) 214-2111.

  
Olga kolesnikBulletin Board, Clinical Care, Education, People, ResearchJune 19, 20170 comments
Read More
Blue-pills

Warning From Office of Public Safety Regarding Carfentanil

Carfentanil tablet

Carfentanil tablet

The University of Maryland, Baltimore Office of Public Safety has issued the following warning to the campus community.

Please be advised that carfentanil – a powerful derivative of fentanyl, a synthetic narcotic analgesic produced from morphine – may potentially be found in Baltimore in either pill form or mixed (“cut”) with heroin. Even small amounts are generally fatal.

Skin contact with the pill could prove fatal to anyone who does not have a high tolerance to opoids.

Avoid Skin Contact

NEVER pick up pills that you find on the street or in the community. If you must pick them up, use latex gloves and standard safety precautions, and notify the UMB police and/or the Baltimore Police Department (911) immediately.

The UMB police can be reached at 771 (on-campus) or 410-706-3333 (off-campus).

Watch out for Your Pets

Carfentanil is deadly to animals, as well. It is used as a tranquilizer for large animals such as elephants. Watch out for your pets when walking outside.

Symptoms of exposure to carfentanil include:

1. Respiratory and cardiac distress
2. Weak pulse
3. Unconsciousness
4. Nausea and vomiting
5. Pinpoint pupils
6. Unusual drowsiness

If you have been exposed, or think you might have been exposed, call 911 or go to your nearest emergency room immediately.

  
Erick PechaBulletin Board, Clinical Care, Community Service, Education, For B'more, People, UMB News, University Administration, University LifeJune 8, 20170 comments
Read More
June President's Message

June President’s Message

Check out the June issue of The President’s Message. It includes Dr. Perman’s column on his State of the University Address, a story on Police Chief Tony Williams’ retirement, a look back at Commencement, a story on Matt Hourihan’s federal research budget forecast, part of the President’s Panel on Politics and Policy, a primer on why philanthropic investment in UMB is so important, a look back at year 2 of the UMB CURE Scholars Program, an invitation to Dr. Perman’s Q&A on June 19, which will include a discussion of the campus climate survey, and a roundup of student, faculty, and staff achievements.

  
Chris Zang ABAE, Bulletin Board, Clinical Care, Collaboration, Community Service, Contests, Education, People, Research, Technology, UMB News, University Life, USGAJune 8, 20170 comments
Read More
Stroke Study

Biogen Acquires Drug Candidate Invented by Marc Simard

Biogen has completed an asset purchase of Remedy Pharmaceuticals’ Phase 3 candidate, CIRARA (intravenous glyburide). The target indication for CIRARA is large hemispheric infarction (LHI), a severe form of ischemic stroke where brain swelling (cerebral edema) often leads to a disproportionately large share of stroke-related morbidity and morality. The U.S. Food and Drug Administration (FDA) recently granted CIRARA Orphan Drug Designation for severe cerebral edema in patients with acute ischemic stroke. The FDA has also granted CIRARA Fast Track designation.

Each year, approximately 1.7 million ischemic strokes occur across the U.S., Europe, and Japan, and approximately 15 percent of these are LHI strokes. In preclinical studies, CIRARA has been shown to block SUR1-TRPM4 channels that mediate stroke-related brain swelling. Clinical proof-of-concept studies have demonstrated the potential of CIRARA to reduce brain swelling, disability, and the risk of death in patients with LHI.

“Building on our leading position in multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease research, we see a compelling opportunity in stroke where we can leverage our core expertise in neuroscience to make a major difference in patient care. CIRARA represents a potential breakthrough stroke treatment that accelerates our efforts to build a portfolio of new therapies for neurologic diseases,” said Michael Ehlers, MD, PhD, executive vice president, research and development at Biogen. “We believe the data supporting the potential of CIRARA are compelling and that CIRARA can be a first-in-class therapy that gives physicians the ability to meaningfully improve patient outcomes in an area where effective treatments have been few and far between.”

This transaction complements Biogen’s broader efforts to build a portfolio of best-in-class treatments for acute ischemic stroke and further strengthen its leadership in neuroscience. Biogen currently is conducting a Phase 2b study to determine whether its monoclonal antibody natalizumab can help patients with acute ischemic stroke improve functional outcomes by limiting brain inflammation in the post-stoke period. If successful, natalizumab and CIRARA will provide new approaches to treating different populations of stroke patients.

Biogen plans to continue the development and commercialization of CIRARA. Under the terms of the agreement, Remedy will share in the cost of development for the target indication for CIRARA in LHI stroke. Biogen will make an upfront payment of $120 million to Remedy and may also pay additional milestone payments and royalties.

About Remedy Pharmaceuticals

Remedy Pharmaceuticals, Inc., is a privately held, clinical stage pharmaceutical company focused on developing and bringing life-saving treatments to people affected by acute central nervous system disease and injuries.

About Biogen

Through cutting-edge science and medicine, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology, and today the company has the leading portfolio of medicines to treat multiple sclerosis; has introduced the first and only approved treatment for spinal muscular atrophy; and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics.

  
Clare BanksClinical Care, Collaboration, On the Move, Research, Technology, UMB News, University AdministrationMay 16, 20170 comments
Read More
Quality Care Network

Pharmacy Partners to Expand Pharmacy Services

The University of Maryland School of Pharmacy has contracted with the University of Maryland Quality Care Network (UMQCN) to provide pharmacy services and case management support to approximately 125,000 patients who receive care under the network. Patients from private insurance, as well as Medicaid and Medicare patients, will receive care coordination services from pharmacy faculty and staff in the network in collaboration with more than 350 primary care providers across Maryland.

“The School of Pharmacy is committed to expanding the role of pharmacists and their impact on pharmacy education, research, and patient care,” says Magaly Rodriguez de Bittner, PharmD, FAPhA, professor in the Department of Pharmacy Practice and Science (PPS) and associate dean for clinical services and practice transformation at the School. “The expertise of our faculty and staff, combined with the innovative resources and programs at the School, uniquely position us to support UMQCN in this endeavor and further advance its pharmacy and case management programs. We are excited to collaborate with UMQCN on this initiative and look forward to working alongside their team to improve health care for thousands of Maryland residents.”

Providing Quality Care to Patients

UMQCN is a provider-organized network of physicians and other health care providers in the state of Maryland. It employs an engaged primary care model, advanced medical management programs, and innovative technology platform to provide patients with high quality, efficiently coordinated, and cost-effective health care services. Through the new contract with UMQCN, faculty and staff from the School of Pharmacy will be responsible for providing a variety of services to patients in the network, including medication management, telehealth management, drug information, and patient and provider education on numerous medication-related issues.

“We are excited to have this opportunity to collaborate so closely with the University of Maryland School of Pharmacy,” says Stacy Garrett-Ray, MD, MPH, MBA, president of the UMQCN. “By leveraging the intellectual capital at the School, we are tapping into a resource that will be very beneficial for our patients.”

Expanding the Pharmacist’s Impact

Integrated into UMQCN’s comprehensive medical management model, the services provided by faculty and staff at the School will mirror those offered through the School’s Maryland P3 Program – a pharmacist-delivered comprehensive medication management program for patients with chronic diseases.

“In the Maryland P3 Program, specially trained pharmacists apply a comprehensive model of care that offers patients step-by-step guidance on medication adherence, lifestyle changes, and self-care skills,” says Rodriguez de Bittner, who also serves as the executive director of the School’s Center for Innovative Pharmacy Solutions (CIPS), a national resource center and leader in the development of innovative patient care and business solutions to health problems, which will oversee the implementation of services under the contract. “By bringing similar services to patients in UMQCN, we are ensuring that the organization remains on the forefront of patient care, delivering high quality pharmacy-related programs to its patients and significant cost savings to its payers.”

Enhancing Education of Future Pharmacists

Faculty and staff working with providers and patients in the UMQCN will also gain new insights in the field of integrated population health management, which will help inform the School’s curriculum and prepare future pharmacists for roles in the field of population health management.

“The School of Pharmacy continues to evolve its curriculum to provide future generations of pharmacists with the knowledge and skills needed to be essential contributors to the health care team,” adds Rodriguez de Bittner. “Through our collaboration with UMQCN, faculty and staff from the School will gain invaluable, firsthand experience in the emerging field of population health management. This experience will enable the School to adapt its curriculum to meet developing needs, provide students with experiential rotations in the field, and potentially develop new revenue generating programs from which faculty, staff, students, and the community alike can benefit.”

Services incorporated in UMQCN as part of this contract began in February 2017.

  
Malissa Carroll Clinical Care, Collaboration, UMB NewsMay 16, 20170 comments
Read More
Mental Health in the Community

Promoting Mental Health in the Local Community

Editor’s Note: This post was originally published on Inside SOP, the University of Maryland School of Pharmacy’s blog. It is reprinted here with permission.

Students, faculty, and staff from the School of Pharmacy collaborated with the Community Engagement Center at the University of Maryland, Baltimore (UMB) to organize new workshops for the center’s ongoing “Healthy Living” series. The team created three interactive classes focused on promoting healthy minds and healthy lives. Community members across West Baltimore were invited to attend the classes and meet and participate with health professionals and guest speakers in group discussions that explored topics such as mental health, stress, and cancer.

Members of the School’s Phi Lambda Sigma Leadership Society (PLS) and College of Psychiatric and Neurologic Pharmacists (CPNP) student chapter, as well as faculty and staff from the PATIENTS Program helped organize and lead the first three classes, which were attended by dozens of community members in total. The classes took place on Thursday afternoons throughout the month of April, and focused on discovering what mental health topics were most important to community members and how we could provide individuals with the resources and skills needed to address these topics.

Dealing With Social Stigma

According to a 2015 report by the Baltimore City Health Department, 23 percent of Baltimore’s adult population does not receive adequate mental health services. This unmet need has led to some serious consequences for the community, including increased rates of homelessness, incarcerations, and unemployment. Hosting these workshops, particularly at this time, was crucial not only for us to gain experience as future health care professionals, but also to help improve the lives of people living in the city.

The workshops focused exclusively on issues associated with social stigma. Participants in the workshops unanimously agreed that social stigma is often a major barrier when an individual considers receiving mental health care. Mental health issues such as substance abuse, depression affected by fear, public perception of the issue, stereotypes, prejudices, and discrimination were thoroughly debated and discussed. The participants agreed that these factors could prevent an individual from getting a proper mental health assessment, and ultimately contribute to an overwhelming number of social and domestic issues such as crime, domestic violence, and unemployment, as individuals who are experiencing mental health issues are less likely to take care of themselves or reach out to receive care in general.

In addition, workshop activities addressed the following areas related to social stigma:

  • Identification of stigmatizing behaviors
  • Influence of stigmatizing behaviors on individuals
  • Influence of stigmatizing behaviors on the community and society
  • Importance of seeking treatment
  • Information about support groups and programs

Helping Baltimoreans Live Healthier Lives

The three mental health workshops that we hosted were a part of the ongoing “Healthy Living” series at the University’s Community Engagement Center, and were held on April 6, 13, and 20.

The first session addressed the topics of depression, grief, and post-traumatic stress disorder caused by violence. The workshop was led by Kelly Quinn, coordinator for the Community Engagement Center, and featured a presentation by Donna Audia, RN, HN-BC, reiki master, from the School of Medicine’s Center for Integrative Medicine, who discussed healing through energy and other issues related to mental and physical health.

Held April 13, the second workshop featured a fruitful panel discussion with faculty from the School of Pharmacy, including Joey Mattingly, PharmD, MBA, assistant professor in the Department of Pharmacy Practice and Science (PPS), Katy Pincus, PharmD, BCPS, assistant professor in PPS, and Jason Noel, PharmD, BCPP, associate professor in PPS, as well as Adrienne Anderson, BSN, RN. Experts and local community members shared their experiences during a round table discussion about mental health. Issues such as smoking cessation, insomnia, stress, anxiety, asthma, access to mental health care, and crime/safety, as well as community involvement were discussed.

In the final session on April 20, Audia returned to talk about stress relief, breathing techniques, and her experiences as a health care professional. In addition, Mattingly and Emily Heil, PharmD, BCPS-AQ infectious diseases, assistant professor in PPS, were present to facilitate the discussion. Pharmacy students spoke about different local resources for mental health support available in downtown and West Baltimore.

Applying the Lessons Participants Learned

The three workshops organized to address the critical topic of mental health in West Baltimore had a lasting impact on the community. These workshops became a platform from which local community members could gather and share their personal experiences. The classes also allowed student pharmacists to bring awareness to some local resources currently available for people in the community. Faculty members and staff from the Community Engagement Center expressed their hope to bring more events hosted by student organizations from the School of Pharmacy to the community to help increase student involvement in establishing new workshops for the community in the near future.

But most importantly, these workshops were a platform from which we were able to raise awareness about the stigma associated with mental illness like never before, leading to discussions that were fruitful, impactful, and will have long-lasting outcomes.

“These three workshops were phenomenal, and had a tremendous impact on the community members, serving as a bridge to help students from the School of Pharmacy learn how to better serve the local community, especially those individuals facing mental health problems,” said Kemahn Jones, a community health intern at the Community Engagement Center. “Community members had an opportunity to meet new, like-minded individuals and learn a great deal of new information to help them moving forward.”

  
Ana Luisa Moreira Coutinho Clinical Care, Community Service, University Life, USGAMay 15, 20170 comments
Read More
IPE - foot screenings

Improving the Health of Homeless Individuals With Diabetes

On April 12, students from the School of Pharmacy participated in a unique outreach event in which we have never previously been involved – collaborating with students in the physical therapy and rehabilitation science (PT) program at the School of Medicine to provide diabetic foot screenings for homeless individuals.

Meeting a Community Need

This interprofessional partnership was prompted by feedback received from the community. In recent years, PT students have volunteered to perform diabetic foot screenings at the Weinberg Housing and Resource Center (WHRC) – the largest emergency shelter in Baltimore that provides resources for homeless individuals, many of whom have been diagnosed with diabetes. The students evaluate each patient’s medical history, vital signs, foot sensation, posture, and provide patient education.
However, one major aspect was missing from this outreach event – knowledge about the medications often prescribed to individuals with diabetes. Many patients had questions about their medications, but the PT students needed assistance providing answers. This need sparked the idea of incorporating an interprofessional approach into the event in which PT and pharmacy students would work together as a team.

Calling in the Medication Experts

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, associate professor in the Department of Pharmacy Practice and Science (PPS) and associate dean for student affairs at the School of Pharmacy, reached out to the American Pharmacists Association-Academy of Student Pharmacists (APhA-ASP) Operation Diabetes’ chair and co-chair – third-year student pharmacist Kyuhee Kim and myself, respectively – to ask if we would like to be involved. Since second-year student pharmacists had recently completed a diabetes module in class, we pulled together a group for an experience that would allow us to apply our knowledge to real-life practice.

A lot of behind-the-scenes planning took place before the event to familiarize pharmacy students with what would be expected and to prepare us for the questions that patients might ask. However, thanks to the combined efforts of faculty members Laurie Neely, PT, DPT; Linda Horn, PT, DScPT, MHS, NCS, GCS; and Layson-Wolf; student pharmacists Stephanos Gozali, Sanchari Gosh, Ghania Naeem, and Amanda Hom; and physical therapy students Nina Fisher, Kimberly Wiman, Eric Sanchez, Shannon Will, and Broderick Bass, we were able to coordinate a successful event.

Working with Patients

Upon arriving to WHRC, each pharmacy student partnered with a PT student to set up five separate screening stations, which allowed us to screen more patients and better work as a comprehensive health care team. Students’ duties were assigned to align with their unique expertise in their individual disciplines, with PT students primarily working to take patients’ medical history, complete the foot screening, and provide education, while pharmacy students took patients’ medication history and vital signs, as well as provided education about medication adherence and disease state/wellness.

Once the patient completed the evaluation, he or she was given a form that detailed his or her vital signs and the information discussed during the screening. Afterwards, all patients were provided with a healthy snack and water as a “thank you” for attending the screening.

Learning from Each Other

We screened 35 patients during the two-hour event, which was an increase over previous years. While the PT students learned a lot about the medications for individuals with diabetes, we also learned a lot about foot screening and functional mobility testing. Although student pharmacists are taught how to conduct diabetic foot screenings, the screenings provided by the PT students were more vigorous, as they asked questions about shoe size/fit and balance.

Through this interprofessional experience, we learned that a collaborative health care team is essential to delivering quality care to patients. The homeless individuals who attended felt fortunate to have experts in different disciplines educate them about their health and answer any questions they had. We thank all who have contributed to the success of this event and look forward to collaborating in the future.

  
Aylin Unal Clinical Care, Collaboration, Community Service, USGAMay 9, 20170 comments
Read More
May President's Message

May President’s Message

Check out the May issue of The President’s Message. It includes Dr. Perman’s column on changing our logo from “The Founding Campus” to “Baltimore,” a story on Malinda Hughes, who gave her $1,500 Employee of the Year prize to the UMB CURE Scholars Program, an invitation to Dr. Perman’s State of the University Address on May 10 and commencement on May 19, a National Mental Health Awareness Month reminder about UMB’s Employee Assistance Program, a safety tip on the UMB Police Force escort service, and a roundup of student, faculty, and staff achievements, including a special section on global health interprofessional projects.

  
Chris Zang Clinical Care, Community Service, Contests, Education, People, Research, Technology, UMB News, University Life, USGAMay 8, 20170 comments
Read More
otc pain relievers

Ask a Pharmacist: Over-the-Counter Pain Relievers

Each day, millions of people visit their local pharmacy to purchase over-the-counter (OTC) pain relievers to help alleviate a wide range of minor aches and pains. Because these medications are available for purchase without a prescription, many people assume that they are risk-free, and safe to use without worry. However, OTC pain relievers like acetaminophen and ibuprofen contain potent compounds that can lead to a number of adverse effects when not used correctly. In fact, researchers have long established that consuming more than the recommended amount of acetaminophen can lead to liver damage, and another recent study from researchers in Denmark found that ibuprofen was associated with a 31 percent increased risk for heart attack.

Although these findings can be frightening at first glance, there is no need for patients to abandon their go-to pain reliever. Below, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, associate professor in the Department of Pharmacy Practice Science (PPS) and associate dean for student affairs at the School of Pharmacy, answers some frequently asked questions about OTC pain relievers and offers guidance to help ensure their appropriate use.

What problems can OTC pain relievers help relieve?

OTC pain relievers can help relieve minor aches and pains, such as muscle soreness, joint pain, and some headaches, and fever. However, the use of OTC pain relievers for these issues should be short term.

How can patients determine which OTC pain reliever is best for them?

Patients should talk with their pharmacist, physician, or other health care provider to discuss which OTC pain reliever is safest for their use. These health care professionals can offer personalized recommendations that take into consideration the patient’s other health conditions and medications.

How can patients ensure that they are using OTC pain relievers safely and correctly?

Patients should carefully read product labels and be sure to take only the recommended dose as indicated on the label. In addition, patients should make sure that they inform all of their health care providers that they are using these products, so that they can be included on their medication lists. Many over-the-counter combination products for cough, cold, and sleep contain the same ingredients found in OTC pain relievers, so some patients might discover that they are unintentionally taking more medication than recommended.

What are some common side effects associated with OTC pain relievers?

Most patients who take acetaminophen, ibuprofen, naproxen, and aspirin do not experience side effects, but those who do might experience nausea and stomach pain. Taking these medications with food can help minimize nausea. However, patients should keep in mind that dangerous side effects could be associated with all OTC medicines, so it’s best to consult with a pharmacist or other health care provider for guidance about which medication is best to take for their unique circumstances.

Can OTC pain relievers be taken safely with patients’ other medications?

Patients should speak with their pharmacist or other health care provider about whether they can safely take OTC pain relievers with their other medications. Each person is likely to have different health conditions and/or take different medications that might affect the safety and effectiveness of OTC pain relievers.

What is the maximum length of time that patients should use OTC pain relievers?

Unless otherwise directed by a health care provider, OTC pain relievers should not be used longer than seven days. If pain or fever persists or is not relieved at the recommended dose on the packaging, patients should visit their health care provider.

Do you have any additional advice for patients who might be thinking about using OTC pain relievers?

Even though some pain relievers are available over-the-counter, they are still medicines and we need to ensure that we are using them safely. OTC pain relievers can be effective for aches and pains, and often, stronger pain medications may not be needed. Talking with your pharmacist or other health care provider can help ensure that you find the best pain reliever for your needs.

  
Malissa Carroll Clinical Care, For B'more, PeopleMay 3, 20170 comments
Read More
drinking-study

Is Your Drinking Getting out of Control?

A clinical trial is being conducted on an investigational medication for the treatment of heavy drinking. This study is open to men and women ages 18 and older and of European ancestry. Participation is confidential and you will be compensated for your time and effort. Transportation can be provided.

University of Maryland, School of Medicine
Department of Psychiatry
Clinical Neurobehavioral Center
667-214-2111
5900 Waterloo Rd.
Columbia, MD

  
Olga KolesnikBulletin Board, Clinical Care, Education, People, ResearchApril 27, 20170 comments
Read More
Opoid Overdose Training

Empowering Students to End the Cycle of Addiction

There is no question that the opioid crisis in Maryland has reached epidemic proportions. In the first three quarters of 2016, the state reported 1,468 unintentional deaths caused by substance abuse, with a majority of the fatalities attributed to heroin and fentanyl. In the same period, there were approximately 500 deaths reported in Baltimore City alone, an increase from approximately 300 the previous year. With overdose numbers this staggering, individuals working in public health and clinical health care have started to wonder what more can they do to address this problem.

Through the Emerging Leaders program, I met an individual from the School of Nursing who invited me to join the planning committee for the Baltimore Area Health Education Center’s (BAHEC) Interdisciplinary Training on Opioid Overdose. We organized an event called “Empowering Students to End the Cycle of Addiction,” which took place on April 8, 2017. Students, staff, and faculty, representing the Graduate School and the Schools of Law, Medicine, Nursing, Pharmacy, and Social Work at the University of Maryland, Baltimore (UMB), came together to learn about the opioid epidemic in Baltimore City and to discuss their professional and personal roles in reducing opioid overdoses. Attendees also left the training certified to administer naloxone – a lifesaving drug that can reverse opioid overdoses.

Preparing Students to Save Lives

The day began with an eye-opening presentation from David Richard Fowler, MD, chief medical examiner for the state of Maryland, in which he presented data on the number of overdose deaths. He discussed the implications that this public health crisis is having on his office, noting that the increase in fatalities has caused a huge strain on his office’s human resources.

Next, Miriam Alvarez, the opioid education and naloxone distribution (OEND) outreach program coordinator at Behavioral Health Systems Baltimore, provided an inspired naloxone training. She engaged the audience by asking questions about their knowledge of opioids and their ability to recognize the signs of an opioid overdose. She stressed that while opioid misuse was once considered a low income, inner-city problem, it affects individuals from all walks of life, and we should all be prepared to respond in the event that we witness an overdose.

Representing the School of Pharmacy, Fadia Shaya, PhD, MPH, professor and vice chair for academic affairs in the Department of Pharmaceutical Health Services Research (PHSR) and director of the Behavioral Health Research Team, discussed the pharmacist’s role in preventing opioid overdose. She spoke about Maryland’s naloxone standing order, which allows registered pharmacists to dispense naloxone without a prescription and discussed different measures that pharmacists and pharmacies can take to ensure that they are actively involved in preventing opioid misuse, including an explanation of the risks of prescription opioids with patients and querying the Prescription Drug Monitoring Program (PDMP) before filling a prescription. Shaya closed her presentation by mentioning a variety of public health prevention programs on which her team works related to this issue.

Making the Discussion Hit Home

Following the presentations, faculty from the medical, dental, and social work schools presented students with a case study that profiled a young man who began misusing prescription opioids following a sports injury, and subsequently developed a dependency on heroin. Faculty encouraged students to identify areas of health care intervention, which sparked a lively discussion among attendees. The event closed with Mellissa Sager, JD, staff attorney at the School of Law, presenting an overview of the Good Samaritan Law and an update from a Baltimore City Health Department representative, who described the city’s response to the opioid overdose epidemic.

This training proved to be a huge success, with more than 55 students attending the Saturday morning training to take action on this important issue. Considering the interest in this event and the urgency of this public health epidemic, the BAHEC plans to host another training in the fall. Everyone at UMB has a role to play in reducing opioid overdoses, and this event provided an opportunity for students, faculty, and staff to become more empowered to do so.

  
Marianne Gibson Clinical Care, Collaboration, Community Service, Education, For B'more, Global & Community Engagement, People, UMB News, University Life, USGAApril 24, 20171 comment
Read More
Lunch and Learn Flow Cytometry

The UMGCCC Lunch and Learn Lecture Series

On May 11, the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) Flow Cytometry Lunch and Learn Lecture Series with Transnational Laboratory Shared Services will present “Advanced imaging cytometry for high throughput cell, colony, and spheroids analysis.”

The UMGCCC Lunch and Learn Lecture Series is a great way to network, learn about new technologies and/or procedures, and make possible collaborations. The event is free. Registration required.

REGISTER NOW

  
Karen Underwood Clinical Care, Collaboration, Education, Research, TechnologyApril 19, 20170 comments
Read More

Health Information Resources for Culturally Diverse Patients

Between 1990 and 2013, the U.S. population identified as having limited English proficiency grew 80 percent, from nearly 14 million to 25.1 million. Cultural diversity within the U.S. continues to increase.

If you provide care for patients or clients with limited English proficiency, do you know the library provides access to a range of quality multilingual, multicultural health information resources? If you’d like to know more about these resources, come to our Health Information Resources for Culturally Diverse Patients workshop.

Learn where to locate patient education resources, including medication information, available in other languages as well as those written in easy-to-read English.

Discussion will include the potential impact utilizing health literacy resources can have on patient adherence, safety, and satisfaction. Visit the Library’s Spring 2017 Workshop Schedule to register.

  
Everly Brown Clinical Care, Collaboration, Community Service, Education, PeopleApril 11, 20170 comments
Read More
President's Message April

April President’s Message

Check out the April issue of The President’s Message. It includes Dr. Perman’s column on the Neighborhood Spring Festival, a story on the generous gift of Drs. Richard and Jane Sherman, an invitation to Dr. Perman’s State of the University Address on May 10, a recap of Frank Bruni’s and Goldie Blumenstyk’s lectures, part of our President’s Panel on Politics and Policy, a look ahead to the next lecture in that series, Matt Hourihan on the federal budget on May 2, a story on our CURE Scholars, who advanced in the Maryland Science Olympiad, a roundup of student, faculty, and staff achievements, and a safety tip on not texting and driving.

  
Chris Zang Clinical Care, Collaboration, Community Service, Contests, Education, People, Technology, UMB News, University Life, USGAApril 10, 20170 comments
Read More